Abstract
The type III polysaccharides of group B Streptococcus in its native state chemically consists of glucose, galactose, glucosamine, and sialic acid. The core of this polysaccharide lacks sialic acid and precipitates with type III antiserum to give a partial identity with the precipitate between the native antigen and this serum. The core determinant is immunochemically similar to the capsular polysaccharide of type XIV Streptococcus pneumoniae, while the native type III group B streptococcal polysaccharide does not cross-react with type XIV pneumococcal antiserum. In human sera, it is antibody directed to the native antigen which correlates very highly with opsonic immunity (r = 0.94) while a poorer correlation exists between antibody to the core antigen and opsonins (r = 0.51 P less than 0.001). In natural infections, as association exists between low levels of maternal antibody to the native antigen and risk of disease in the infant. This association is not true for antibody to the core structure, where both infected infants and their mothers have much higher levels of antibody to the core than the native antigens. Infected infants are also more likely to respond to infection by developing antibody to the native antigen. Immunization of 12 adults with multivalent pneumococcal polysaccharide induced significantly better antibody response to the core antigen than to the native, and this vaccine induced opsonic activity in only one recipient. Immunization of adults with type III group B streptococcal antigens induced antibody to the native determinant which correlated with opsonic activity. Therefore, it would appear that native group B streptococcal polysaccharides will provide the best candidate antigens for immunization.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baker C. J., Edwards M. S., Kasper D. L. Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest. 1978 Apr;61(4):1107–1110. doi: 10.1172/JCI109011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baker C. J., Kasper D. L., Tager IRAB, Paredes A., Alpert S., McCormack W. M., Goroff D. Quantitative determination of antibody to capsular polysaccharide in infection with type III strains of group B Streptococcus. J Clin Invest. 1977 May;59(5):810–818. doi: 10.1172/JCI108703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baltimore R. S., Kasper D. L., Baker C. J., Goroff D. K. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci. J Immunol. 1977 Feb;118(2):673–678. [PubMed] [Google Scholar]
- Fikrig S. M., Schiffman G., Phillipp J. C., Moel D. I. Antibody response to capsular polysaccharide vaccine of Streptococcus pneumoniae in patients with nephrotic syndrome. J Infect Dis. 1978 Jun;137(6):818–821. doi: 10.1093/infdis/137.6.818. [DOI] [PubMed] [Google Scholar]
- Gotschlich E. C., Rey M., Triau R., Sparks K. J. Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest. 1972 Jan;51(1):89–96. doi: 10.1172/JCI106801. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lancefield R. C. A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B). J Exp Med. 1934 Mar 31;59(4):441–458. doi: 10.1084/jem.59.4.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lancefield R. C., Freimer E. H. Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond) 1966 Jun;64(2):191–203. doi: 10.1017/s0022172400040456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lancefield R. C. TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES. J Exp Med. 1938 Jan 1;67(1):25–40. doi: 10.1084/jem.67.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lindberg B., Lönngren J., Powell D. A. Structural studies on the specific type-14 pneumococcal polysaccharide. Carbohydr Res. 1977 Sep;58(1):177–186. doi: 10.1016/s0008-6215(00)83413-8. [DOI] [PubMed] [Google Scholar]
- Russell H., Norcross N. L. The isolation and some physiochemical and biologic properties of the type 3 antigen of group B streptococci. J Immunol. 1972 Jul;109(1):90–96. [PubMed] [Google Scholar]
- Siber G. R., Weitzman S. A., Aisenberg A. C., Weinstein H. J., Schiffman G. Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med. 1978 Aug 31;299(9):442–448. doi: 10.1056/NEJM197808312990903. [DOI] [PubMed] [Google Scholar]
- Sullivan J. L., Ochs H. D., Schiffman G., Hammerschlag M. R., Miser J., Vichinsky E., Wedgwood R. J. Immune response after splenectomy. Lancet. 1978 Jan 28;1(8057):178–181. doi: 10.1016/s0140-6736(78)90612-8. [DOI] [PubMed] [Google Scholar]
- Wilkinson H. W. Detection of group B streptococcal antibodies in human sera by radioimmunoassay: concentrations of type-specific antibodies in sera of adults and infants infected with group B streptococci. J Clin Microbiol. 1978 Feb;7(2):194–201. doi: 10.1128/jcm.7.2.194-201.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson H. W., Eagon R. G. Type-specific antigens of group B type Ic streptococci. Infect Immun. 1971 Nov;4(5):596–604. doi: 10.1128/iai.4.5.596-604.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson H. W. Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic. Infect Immun. 1975 Apr;11(4):845–852. doi: 10.1128/iai.11.4.845-852.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson H. W. Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic. Infect Immun. 1975 Apr;11(4):845–852. doi: 10.1128/iai.11.4.845-852.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]